Taneja V - Search Results

1

HLA class II molecules influence susceptibility versus protection in inflammatory diseases by determining the cytokine profile.

Mangalam AK, Taneja V, David CS. Mangalam AK, et al. Among authors: taneja v. J Immunol. 2013 Jan 15;190(2):513-8. doi: 10.4049/jimmunol.1201891. J Immunol. 2013. PMID: 23293357 Free PMC article. Review.

2

Polymorphism of HLA-DRB, -DQA1, and -DQB1 in rheumatoid arthritis in Asian Indians: association with DRB1*0405 and DRB1*1001.

Taneja V, Giphart MJ, Verduijn W, Naipal A, Malaviya AN, Mehra NK. Taneja V, et al. Hum Immunol. 1996 Mar;46(1):35-41. doi: 10.1016/0198-8859(95)00165-4. Hum Immunol. 1996. PMID: 9157087

3

Expression of the H2-E molecule mediates protection to collagen-induced arthritis in HLA-DQ8 transgenic mice: role of cytokines.

Taneja V, Hansen J, Smart M, Griffiths M, Luthra H, David CS. Taneja V, et al. Int Immunol. 1997 Aug;9(8):1213-9. doi: 10.1093/intimm/9.8.1213. Int Immunol. 1997. PMID: 9263019

4

HLA transgenic mice as humanized mouse models of disease and immunity.

Taneja V, David CS. Taneja V, et al. J Clin Invest. 1998 Mar 1;101(5):921-6. doi: 10.1172/JCI2860. J Clin Invest. 1998. PMID: 9486959 Free PMC article. Review. No abstract available.

5

Expression of the human histocompatibility leukocyte antigen DR3 transgene reduces the severity of demyelination in a murine model of multiple sclerosis.

Drescher KM, Nguyen LT, Taneja V, Coenen MJ, Leibowitz JL, Strauss G, Hammerling GJ, David CS, Rodriguez M. Drescher KM, et al. Among authors: taneja v. J Clin Invest. 1998 Apr 15;101(8):1765-74. doi: 10.1172/JCI167. J Clin Invest. 1998. PMID: 9541508 Free PMC article.

6

HLA-DR/DQ transgenic, class II deficient mice as a novel model to select for HSP T cell epitopes with immunotherapeutic or preventative vaccine potential.

Geluk A, Taneja V, van Meijgaarden KE, de Vries RR, David CS, Ottenhoff TH. Geluk A, et al. Among authors: taneja v. Biotherapy. 1998;10(3):191-6. doi: 10.1007/BF02678296. Biotherapy. 1998. PMID: 9559973

7

Identification of HLA class II-restricted determinants of Mycobacterium tuberculosis-derived proteins by using HLA-transgenic, class II-deficient mice.

Geluk A, Taneja V, van Meijgaarden KE, Zanelli E, Abou-Zeid C, Thole JE, de Vries RR, David CS, Ottenhoff TH. Geluk A, et al. Among authors: taneja v. Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10797-802. doi: 10.1073/pnas.95.18.10797. Proc Natl Acad Sci U S A. 1998. PMID: 9724784 Free PMC article.

8

Modulation of HLA-DQ-restricted collagen-induced arthritis by HLA-DRB1 polymorphism.

Taneja V, Griffiths MM, Luthra H, David CS. Taneja V, et al. Int Immunol. 1998 Oct;10(10):1449-57. doi: 10.1093/intimm/10.10.1449. Int Immunol. 1998. PMID: 9796911

9

HLA class II transgenic mice as models of human diseases.

Taneja V, David CS. Taneja V, et al. Immunol Rev. 1999 Jun;169:67-79. doi: 10.1111/j.1600-065x.1999.tb01307.x. Immunol Rev. 1999. PMID: 10450509 Review.

10

Complementation between HLA-DR4 (DRB1*0401) and specific H2-A molecule in transgenic mice leads to collagen-induced arthritis.

Pan S, Taneja V, Griffiths MM, Luthra H, David CS. Pan S, et al. Among authors: taneja v. Hum Immunol. 1999 Sep;60(9):816-25. doi: 10.1016/s0198-8859(99)00070-1. Hum Immunol. 1999. PMID: 10527388

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

224 results

Search Page

Filters